A method of treating a mammal for a purpose selected from the group consisting of (a) increasing bone mineral density (BMD), (b) treating low BMD, (c) preventing and treatment of low impact fractures, (d) treatment of high impact fractures; (e) treating osteoporosis; (f) modulating a growth factor that influences bone metabolism; and (g) improving bone micro-architecture or connectivity of bone; the method comprising administering to the mammal an effective amount of a N-acylated-2-glucosamine derivative of the general formula (I): ##STR00001## wherein R is an alkyl radical of the general formula C.sub.nH.sub.2n+1 and n is selected from 2-12; or pharmaceutically-acceptable salts, esters and glucosides thereof; or pharmaceutically-acceptable compositions thereof.

 
Web www.patentalert.com

< Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics

> Harvest-inducible genes from alfalfa (Medicago sativa) and methods of use thereof

~ 00464